Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded quarterly EPS (Basic) of $6.99 in Q1 2026, down 15.17% quarter-over-quarter from $8.24 in Q4 2025, and down 7.78% on a YoY basis from $7.58 in Q1 2025.
Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' EPS (Basic) history runs 18 years deep, the most recent figure standing at $6.99 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 7.78% year-over-year to $6.99; the TTM figure through Mar 2026 stood at $42.56 (up 1.89% YoY), while the FY2025 annual figure was $43.07, up 5.31% from the prior year.
- EPS (Basic) was $6.99 for Q1 2026 at Regeneron Pharmaceuticals, down from $8.24 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $14.09 in Q3 2025 to a low of $6.7 in Q1 2024.
- Historically, EPS (Basic) has averaged $9.92 across 5 years, with a median of $9.12 in 2022.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 73.23% in 2022, then soared 46.41% in 2024.
- A 5-year view of EPS (Basic) shows it stood at $11.21 in 2022, then retreated by 2.85% to $10.89 in 2023, then fell by 21.58% to $8.54 in 2024, then dropped by 3.51% to $8.24 in 2025, then retreated by 15.17% to $6.99 in 2026.
- The last three EPS (Basic) figures came in at $6.99 (Q1 2026), $8.24 (Q4 2025), and $14.09 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.99 |
| Dec 31, 2025 | 8.24 |
| Sep 30, 2025 | 14.09 |
| Jun 30, 2025 | 13.24 |
| Mar 31, 2025 | 7.58 |
| Dec 31, 2024 | 8.54 |
| Sep 30, 2024 | 12.40 |
| Jun 30, 2024 | 13.25 |
| Mar 31, 2024 | 6.70 |
| Dec 31, 2023 | 10.89 |
| Sep 30, 2023 | 9.48 |
| Jun 30, 2023 | 9.05 |
| Mar 31, 2023 | 7.64 |
| Dec 31, 2022 | 11.21 |
| Sep 30, 2022 | 12.31 |
| Jun 30, 2022 | 7.90 |
| Mar 31, 2022 | 9.12 |
| Dec 31, 2021 | 20.98 |
| Sep 30, 2021 | 15.37 |
| Jun 30, 2021 | 29.51 |